"Brain Health Support: NIMONIDIP 30 (Nimodipine BP 30mg)"

May 25, 2024

NIMONIDIP 30 

Nimodipine BP(30mg)

Introduction

NIMONIDIP 30, containing Nimodipine BP (30mg), is a medication renowned for its role in promoting brain health and managing conditions affecting cerebral blood flow. It belongs to the calcium channel blocker class and is commonly used to prevent vasospasm following a subarachnoid hemorrhage, ensuring adequate blood flow to the brain.

Uses

  • Vasospasm Prevention: NIMONIDIP 30 is primarily prescribed to prevent vasospasm after a subarachnoid hemorrhage, which can lead to reduced blood flow in the brain and neurological complications.
  • Cerebral Blood Flow: It works by relaxing blood vessels in the brain, improving cerebral blood flow, and supporting optimal brain function.
  • Neurological Support: In addition to its primary use, Nimodipine BP may be beneficial in managing other neurological conditions under medical supervision.

Dosage

  • Recommended Dosage: The standard dose of Nimodipine BP (30mg) is one tablet taken orally every four hours, totaling six doses daily.
  • Administration: Taking the medication with food or water helps minimize gastrointestinal discomfort.
  • Duration: Treatment duration is typically 21 days, as prescribed by a healthcare provider.

Side Effects

  • Common Side Effects: Headache, dizziness, flushing, nausea, and low blood pressure are common side effects that may occur. These effects are generally mild and resolve with continued use.
  • Serious Side Effects: Although rare, serious side effects such as allergic reactions, irregular heartbeat, and breathing difficulties may require immediate medical attention.
  • Monitoring: Regular monitoring by healthcare professionals is important to detect and manage any potential side effects promptly.

Precautions

  • Medical History: Inform your doctor about any pre-existing medical conditions, including low blood pressure, heart problems, liver disease, and allergies.
  • Pregnancy and Nursing: Consult your doctor before using Nimodipine BP if you are pregnant, planning pregnancy, or breastfeeding.
  • Medication Interactions: Provide a comprehensive list of all medications, supplements, and herbal products you are taking to avoid interactions with Nimodipine BP.

Conclusion

NIMONIDIP 30, with its active ingredient Nimodipine BP (30mg), is instrumental in promoting brain health and managing cerebral blood flow-related conditions. When used as directed by healthcare providers, it can significantly reduce the risk of complications after a subarachnoid hemorrhage and improve neurological outcomes. Adhering to prescribed dosages and guidelines ensures safe and effective use of NIMONIDIP 30 for enhanced brain health.

Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 

 

 

 

 

SHARE WITH